Health

Hospitals’ next lucrative bet — longevity clinics

Read full article at source ↗

Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 16/10/2026, 15:36:24 UTC.

Briefings

A STAT podcast episode examines the multitrillion-dollar longevity medicine industry, featuring reporter Sarah Todd at a clinic in a major hospital. The discussion explores whether this booming sector is driven by genuine medical need or commercial incentives, with no specific patient outcomes or financial figures provided in the source.

Key points

• The longevity medicine industry is estimated to be worth trillions of dollars.
• STAT reporter Sarah Todd visited a longevity clinic at a major hospital to discuss the sector's commercial nature.

Context

This episode of The Readout LOUD explores the intersection of biotech and healthcare, specifically the rapid expansion of longevity clinics in major hospitals across the United States.

Limitations

The source provides no specific dates, patient numbers, financial costs, or clinical results. It does not confirm whether the clinics are profitable or if the treatments work, leaving the economic and medical viability of the sector unverified.

Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 16/10/2026, 19:51:52 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.

View archived briefing on IPFS
bafybeidtthd7jtlpwljczrjbvlqvzxewyljrhr2vbochvslhlpzhv7udzy